INDV
NASDAQ · Pharmaceuticals
Indivior Pharmaceuticals Inc
$38.32
+0.02 (+0.05%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.83%
1Y
+174.70%
YTD
+7.25%
Open$38.28
Previous Close$38.30
Day High$38.89
Day Low$37.64
52W High$41.00
52W Low$13.45
Volume—
Avg Volume1.71M
Market Cap4.67B
P/E Ratio18.60
EPS$1.94
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$34.90
Above
SMA 200
$24.61
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
+26.6% upside
Current
$38.32
$38.32
Target
$48.50
$48.50
$40.68
$48.50 avg
$71.11
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.18B | 1.06B | 1.33B |
| Net Income | 200.03M | 161.89M | 235.99M |
| Profit Margin | 17.0% | 16.1% | 17.8% |
| EBITDA | 249.56M | 213.21M | 342.24M |
| Free Cash Flow | — | — | 277.67M |
| Rev Growth | +11.2% | +11.2% | +22.2% |
| Debt/Equity | 5.43 | 5.43 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,108.83 | +0.61% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $238.07 | +2.93% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.15 | +3.18% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.91 | -0.68% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.90 | +2.19% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.92 | +1.36% | 12.5 | 33.00B |